Who owns my DNA?: The national and international intellectual property laws on human embryonic tissue and cloning Read more about Who owns my DNA?: The national and international intellectual property laws on human embryonic tissue and cloning
Intellectual property and the human genome (part ii) Read more about Intellectual property and the human genome (part ii)
Intellectual property and the human genome (part i) Read more about Intellectual property and the human genome (part i)
Designing an optimal intellectual property system for plants: A U.S. Supreme Court debate Read more about Designing an optimal intellectual property system for plants: A U.S. Supreme Court debate
Public access versus proprietary rights in genomic information: What is the proper role of intellectual property rights? Read more about Public access versus proprietary rights in genomic information: What is the proper role of intellectual property rights?
Navigating uncharted waters: Intellectual property rights surrounding genomics research and development information Read more about Navigating uncharted waters: Intellectual property rights surrounding genomics research and development information
Is policy towards intellectual property rights addressing the real problems? The case of unauthorized appropriation of genetic resources Read more about Is policy towards intellectual property rights addressing the real problems? The case of unauthorized appropriation of genetic resources
Beyond blue gene: Intellectual property and bioinformatics Read more about Beyond blue gene: Intellectual property and bioinformatics
The dilemma of intellectual property rights for pharmaceuticals: The tension between ensuring access of the poor to medicines and committing to international agreements Read more about The dilemma of intellectual property rights for pharmaceuticals: The tension between ensuring access of the poor to medicines and committing to international agreements
The Supreme Court's war on intellectual property Read more about The Supreme Court's war on intellectual property